Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Baiyunshan Pharmaceutical Holdings Waste Data Preview
In 2023, Baiyunshan Pharmaceutical Holdings conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Waste Generated | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Waste Recovered | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Non-Hazardous Waste Disposed | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Verified Sources Behind Baiyunshan Pharmaceutical Holdings’s Waste Management Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Baiyunshan Pharmaceutical Holdings’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Insights into Baiyunshan Pharmaceutical Holdings’s Generation of Hazardous and Non-Hazardous Waste
In 2023, Baiyunshan Pharmaceutical Holdings generated a total of 50,651 metric tonnes of waste. a
Of this amount, 2.15% of Baiyunshan Pharmaceutical Holdings's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 97.85% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls. a
Baiyunshan Pharmaceutical Holdings’s Hazardous vs Non-Hazardous Waste Over Time
- Total Non-Hazardous Waste Generated
- Total Hazardous Waste Generated
How Baiyunshan Pharmaceutical Holdings reduced the environmental impact of its waste?
Since 2021, Baiyunshan Pharmaceutical Holdings's total waste generation increased by 98.23%, including a 35.28% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems. a
Over the same period, Baiyunshan Pharmaceutical Holdings reduced the hazardousness of its waste by 11.33%, with a further 8.9% decline in 2023, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact. a
Overall, Baiyunshan Pharmaceutical Holdings is generating more waste but has significantly reduced the share of hazardous materials, suggesting a partial decoupling of volume and toxicity that could reflect more responsible inputs or enhanced treatment. a